Research study Program year 2023 Source: CMS Open Payments

Tv44749-Sad-10154

Research payments

$6,795,881

110 payments

Through program year 2023, $6,795,881 in research payments was reported against Tv44749-Sad-10154, across 110 payments, paid by Teva Pharmaceuticals USA, Inc..

Paid by: Teva Pharmaceuticals USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$614,622	6
2022	Research	$1,992,650	51
2021	Research	$3,692,205	39
2020	Research	$496,404	14

Breakdown

Who paid Research payments · program years 2020–2023

Teva Pharmaceuticals USA, Inc. $6,795,881 110 payments

Who received the money Research payments · program years 2020–2023

Hassman Research Institute Organisation paid for research $3,056,673 50 payments
Atlanta Center For Medical Research Organisation paid for research $2,868,607 44 payments
Community Clinical Research Organisation paid for research $870,601 16 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.